Experience

Juvena Therapeutics
• United States
• Biotechnology Research
• 1 - 100 Employee
• Scientist II

  • Mar 2023 - Present


Penn State College of Medicine

• United States
• Higher Education
• 700 & Above Employee

• Postdoctoral Researcher

  • Dec 2017 - Feb 2023

  • Novel findings present elevated GRK2 signaling in chondrocytes as a driver of cartilage degradation and paroxetine as a disease-modifying drug for synovitis and Osteoarthritis treatment • Established new methods to study the role of GRK2 signaling in macrophage/immune cells in aging mouse models. • Achieved First author in leading scientific journals, Science Translational Medicine, & International Journal of Molecular Sciences. As a co-author, I have published several research articles. • Exhibited excellent working skills ranging from developing comprehensive project plans, formulating hypotheses, result-oriented experimentation, data interpretation and analysis. Show less



Department of Clinical Pharmacology, Niigata university of Pharmacy and Applied Life Sciences, Japan

• Research Associate

  • Dec 2012 - Mar 2017

  • Our novel findings discovered small molecule disruption of G protein βγ subunit signaling reprograms human macrophage phenotype and prevents autoimmune myocarditis in rats • We identified the HMGB1 signaling drive an important role in skin inflammation, and quercetin/resveratrol treatments could be a promising agent for atopic dermatitis. • Also, independently investigated the cancer drug induced nephrotoxicity and cardiotoxicity in animal models and treatment options. • Gained in-depth research experience in the field of pharmacology, immunology, and molecular biology, transgenic animal model and fluorescent/confocal imaging techniques. Show less


K.M.C.H. COLLEGE OF PHARMACY (Inst. Code - 114), COIMBATORE
• India
• Higher Education
• 1 - 100 Employee
• Lecturer

  • Sep 2010 - Oct 2012

Torrent Pharma Inc.
• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee
• Medical Representative

  • Sep 2007 - May 2008